Navan Selected by Opella to Streamline Global Travel and Expense
15.4.2026 09:01:00 CEST | Business Wire | Press Release
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense management platform, today announced it has been selected by Opella to manage its global travel and expense programme.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415188706/en/
Self-care company aims to simplify employee T&E experience and targets cost savings with AI-powered platform
“Navan provides our teams with an easy-to-use tool that removes the complexity from business travel and expense, improving our employee experience and giving us the real-time visibility required to effectively manage costs,” said Vincent Cotard, VP Global Head Real Estate and Workplace Experience at Opella. "Our employees will now have the easiest way to book travel and manage their expenses as we look to automate processes across the business.”
Following Opella’s carve-out from Sanofi, the self-care company sought an AI-powered partner to provide employees with an easy-to-use travel platform and to optimize spending. Initial conversations began about Navan's travel product and Opella extended the partnership to also include Navan’s expense product, giving them end-to-end control and visibility of their entire travel and expense outlay.
Anticipated benefits from the partnership with Navan include:
- Cost savings: Targeting savings of up to 20% on annual travel spend through access to competitive pricing and reduced fees.
- High adoption: Aiming for 95% platform adoption and a 96% traveller satisfaction score.
- Operational efficiency: Saving an estimated 15 minutes per booking through AI-assisted capabilities and improved self-serve access across both web and mobile applications.
“We’re thrilled to partner with Opella to modernise their global travel and expense programme,” said Zahir Abdelouhab, SVP, EMEA, Navan. “By addressing issues with their existing inventory, we are confident that Opella will achieve the adoption rates and savings necessary to meet their goals.”
Opella joins a growing list of enterprise organizations that have recently switched to Navan, including industry leaders from across France, including Alcatel-Lucent, Lafarge, and Expleo.
About Opella
Opella is the self-care challenger with the purest and third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health into people’s hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting. At the core of this mission is our 100 loved brands, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many of the world’s most loved brands, including Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale and Mucosolvan. B Corp certified globally, we are active players in the journey towards healthier people and planet.
About Navan
Navan (NASDAQ: NAVN) is the global AI-powered business travel and expense platform that makes travel easy for frequent travelers. From finding flights and hotels, to automating expense reconciliation, with 24/7 support along the way, Navan delivers an intuitive experience travelers love and finance teams rely on. See how Navan customers benefit and learn more at navan.com.
Forward Looking Statements
All statements in this press release other than statements of historical fact could be deemed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” or similar expressions. Such statements are subject to risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. These risks and other factors include the risks described under the caption “Risk Factors” in Navan’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on April 2, 2026, as they may be updated by Navan’s subsequent filings with the SEC. Except as required by law, Navan undertakes no obligation, and does not intend, to update these forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260415188706/en/
Contacts
Navan Press press@navan.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Method Enables Structural Determination of Diverse Phenolic Compounds from a Tiny Alpine Flower Sample15.4.2026 16:00:00 CEST | Press Release
Hyuga Hirano (United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology, and collaborative graduate student at the National Museum of Nature and Science (President: Makoto Manabe)); Takashi Kikuchi (Application Laboratories, Global Product Unit, Rigaku Corporation, a group company of Rigaku Holdings); Futa Sakakibara (Technical Advisor, R&D Support Division, Asterism G.K.); Yoshinori Murai (Senior curator, Department of Botany, National Museum of Nature and Science); and colleagues have successfully determined the structures of more than ten phenolic glycosides from a tiny sample of an alpine plant flower by developing a trace analysis method. This achievement is particularly significant because alpine plants are typically small and difficult to collect due to legal, ethical, and environmental considerations, resulting in extremely limited sample availability. Determining the structures of numerous chemical components from such a small sample repres
New Method Enables Structural Determination of Diverse Phenolic Compounds from a Tiny Alpine Flower Sample15.4.2026 16:00:00 CEST | Press Release
Hyuga Hirano (United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology, and collaborative graduate student at the National Museum of Nature and Science (President: Makoto Manabe)); Takashi Kikuchi (Application Laboratories, Global Product Unit, Rigaku Corporation, a group company of Rigaku Holdings); Futa Sakakibara (Technical Advisor, R&D Support Division, Asterism G.K.); Yoshinori Murai (Senior curator, Department of Botany, National Museum of Nature and Science); and colleagues have successfully determined the structures of more than ten phenolic glycosides from a tiny sample of an alpine plant flower by developing a trace analysis method. This achievement is particularly significant because alpine plants are typically small and difficult to collect due to legal, ethical, and environmental considerations, resulting in extremely limited sample availability. Determining the structures of numerous chemical components from such a small sample repres
BM3EAC Corp. 2025 Annual Report15.4.2026 16:00:00 CEST | Press Release
BM3EAC Corp. (the “Company”), a special purpose acquisition company incorporated under the laws of the Cayman Islands as an exempted company with limited liability and listed on Euronext Amsterdam, the regulated market operated by Euronext Amsterdam N.V., today published its annual report for the period 1 January 2025 to 31 December 2025. The annual report can be downloaded from the Company’s website via the following link: https://www.BrigadeM3EAC.com/documents IMPORTANT INFORMATION This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DISCLAIMER The Company’s annual report referenced in this announcement may include forward-looking statements, which are based on the Company's current expectations and projections regarding a business combination, the business, the economy and other future conditions of the Company and speak only as of the date hereof. Forward-looking statements may and often d
Forrester’s Top 10 Emerging Technologies For 2026: AI Is No Longer Confined To Digital Workflows15.4.2026 15:30:00 CEST | Press Release
Forrester (Nasdaq: FORR) today released its The Top 10 Emerging Technologies In 2026 report, which highlights a pivotal shift in AI from digital experimentation to real-world transformation. AI is moving beyond software into physical environments — powering robots, vehicles, and ambient experiences that are already changing how consumers communicate, work, and buy. As the pace of AI innovation continues, agentic software and physical AI will shape what consumers experience next, while technologies such as frontier models and AI security will be foundational to fueling future innovation. The research categorizes the top 10 emerging technologies by their impacts over short-term, medium-term, and long-term benefit horizons to help enterprises and leaders prioritize their investments. Key findings include: Short-term emerging technologies that are quickly moving from trial to real use, delivering benefits to early adopters with solid business cases within the next two years: Agentic commer
Forrester’s Top 10 Emerging Technologies For 2026: AI Is No Longer Confined To Digital Workflows15.4.2026 15:30:00 CEST | Press Release
Forrester (Nasdaq: FORR) today released its The Top 10 Emerging Technologies In 2026 report, which highlights a pivotal shift in AI from digital experimentation to real-world transformation. AI is moving beyond software into physical environments — powering robots, vehicles, and ambient experiences that are already changing how consumers communicate, work, and buy. As the pace of AI innovation continues, agentic software and physical AI will shape what consumers experience next, while technologies such as frontier models and AI security will be foundational to fueling future innovation. The research categorizes the top 10 emerging technologies by their impacts over short-term, medium-term, and long-term benefit horizons to help enterprises and leaders prioritize their investments. Key findings include: Short-term emerging technologies that are quickly moving from trial to real use, delivering benefits to early adopters with solid business cases within the next two years: Agentic commer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom